Effectiveness of paroxetine in the treatment of acute major depression in adults: a systematic re-examination of published and unpublished data from randomized trials

C Barbui, TA Furukawa, A Cipriani - Cmaj, 2008 - Can Med Assoc
Background: Concern has been raised about the efficacy of antidepressant therapy for major
depression in adults. We undertook a systematic review of published and unpublished …

[HTML][HTML] Randomized, placebo-controlled trials of antidepressants for acute major depression: thirty-year meta-analytic review

J Undurraga, RJ Baldessarini - Neuropsychopharmacology, 2012 - nature.com
Antidepressant–placebo response-differences (RDs) in controlled trials have been
declining, potentially confounding comparisons among older and newer drugs. For clinically …

A meta-analysis of the efficacy and tolerability of paroxetine versus tricyclic antidepressants in the treatment of major depression

SA Montgomery - International clinical psychopharmacology, 2001 - journals.lww.com
This meta-analysis examined efficacy and tolerability data from 39 randomized, double-
blind, parallel-group studies comparing paroxetine (n= 1924) with clomipramine (n= 141) or …

Paroxetine versus other anti‐depressive agents for depression

M Purgato, D Papola, C Gastaldon… - Cochrane Database …, 2014 - cochranelibrary.com
Background Paroxetine is the most potent inhibitor of the reuptake of serotonin of all
selective serotonin reuptake inhibitors (SSRIs) and has been studied in many randomised …

Initial severity of major depression and efficacy of new generation antidepressants: individual participant data meta‐analysis

TA Furukawa, K Maruo, H Noma… - Acta Psychiatrica …, 2018 - Wiley Online Library
Objective The role of baseline severity as effect modifier in various psychiatric disorders is a
topic of controversy and of clinical import. This study aims to examine whether baseline …

A comparison of paroxetine and placebo in depressed outpatients

GC Dunbar, JL Claghorn, A Kiev… - Acta psychiatrica …, 1993 - Wiley Online Library
To compare the safety and efficacy of paroxetine (n= 167) and placebo (n= 169), data from 4
centres using the same protocol were pooled. A double‐blind parallel group design was …

Metareview on short-term effectiveness and safety of antidepressants for depression: an evidence-based approach to inform clinical practice

A Cipriani, JR Geddes, TA Furukawa… - … Canadian Journal of …, 2007 - journals.sagepub.com
Objectives: To examine the available scientific literature for answers to clinically relevant
questions regarding the effectiveness and tolerability of antidepressant drugs (ADs) for the …

Does randomized evidence support sertraline as first-line antidepressant for adults with acute major depression? A systematic review and meta-analysis

A Cipriani, TA Furukawa, JR Geddes, L Malvini… - J Clin …, 2008 - psychiatrist.com
Objective: Preliminary evidence suggested that sertraline might be slightly superior to other
antidepressant medications in terms of efficacy. The aim of this study was to carry out a …

Paroxetine versus placebo: a double-blind comparison in depressed patients.

JL Claghorn, A Kiev, K Rickels, WT Smith… - The Journal of clinical …, 1992 - europepmc.org
Background Paroxetine is a potent and selective serotonin reuptake inhibitor (SSRI). The
present study assessed the efficacy and tolerability of paroxetine against placebo in …

General and comparative efficacy and effectiveness of antidepressants in the acute treatment of depressive disorders: a report by the WPA section of …

TC Baghai, P Blier, DS Baldwin, M Bauer… - European archives of …, 2011 - Springer
Current gold standard approaches to the treatment of depression include
pharmacotherapeutic and psychotherapeutic interventions with social support. Due to …